- November 4, 2020
- Posted by: Jeff Kish
- Categories: Healthcare Research Technologies News, Latest News, Mobile Apps & Serious Games News, Research & Development News, Wearable Design & Manufacturing News
ROCKVILLE, Md.—September 16, 2020—Intelligent Automation, Incorporated (IAI), a technology innovation company, announced today that it has been awarded a contract by the National Institutes of Health’s (NIH) National Cancer Institute (NCI) to develop a platform for automated analysis of physical activity, performance, and behavior in still and video images for clinical and home monitoring of patients.
In this contract, IAI’s solution will collect and automatically analyze images and data from patient activities including automated assessments of gait, walking speed, and other medically relevant performance parameters. Use in clinical evaluation and in-home monitoring will improve evaluation of patient physical activity. The platform will facilitate cancer prevention and control through improved evaluation of interventions that encourage physical activity, automation of symptom monitoring for patients with diseases that affect physical performance, and improved patient compliance with physical therapy rehabilitation regimens.
“IAI is proud to have been selected by NIH/NCI to support the development of technology for monitoring and improving the physical health of cancer patients,” said Vikram Manikonda, President and CEO of IAI.
IAI’s digital healthcare team creates mobile apps and sensors to gather and analyze data from patients outside of the clinical setting. Researchers and practitioners use IAI’s technologies in medical informatics to improve patient outcomes by monitoring patient performance, improving adherence, and providing timely interventions throughout a patient’s healthcare regimen.
IAI is a technology innovation company specializing in providing advanced technology solutions and R&D services to federal agencies and corporations. IAI leverages agile R&D processes, a multi-disciplinary collaborative environment, and a substantial intellectual property portfolio to develop concepts into market-focused products and customer-driven solutions. IAI’s core R&D areas include: AI & Advanced Computing; Autonomy & Robotics; Healthcare Research Technologies; Modeling, Simulation & Visualization; Networks & Cyber Security; and Radar, Communications & Sensors. For more information about IAI, please visit www.i-a-i.com.